Ignite Creation Date:
2024-05-06 @ 12:26 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03761537
Status:
COMPLETED
Last Update Posted:
2023-06-06
First Post:
2018-11-30
Brief Title:
Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Organization Data
Organization:
LEO Pharma
Class:
INDUSTRY
Study ID:
LP0162-1346
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LEO Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None